Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 33 Neoplasms 25 Prostatic Neoplasms 16 Colorectal Neoplasms 13 Lung Neoplasms 11 Multiple Myeloma 9 Head and Neck Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Pancreatic Neoplasms 6 Neoplasm Metastasis 6 Urinary Bladder Neoplasms 5 Hematologic Neoplasms 5 Gastrointestinal Neoplasms 5 Advanced Cancer 5 Uterine Cervical Neoplasms 4 Smoking Cessation 4 Ovarian Neoplasms 4 Melanoma 4 Leukemia 4 Colonic Neoplasms 4 Anxiety Disorders 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Recurrence 3 Rectal Neoplasms 3 Neoplasms, Plasma Cell 3 Motor Activity 3 Lymphoma, Follicular 3 Lymphedema 3

Interventions

ostarine 3 rimabotulinumtoxinB 1 Standard of Care 1 Olanzapine 1 Enteral Nutrition 1 Cyproheptadine 1 Creatine 1 Botulinum Toxins, Type A 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Muscular Atrophy × Standard of Care × Clear all

NCT06175273 2025-09-18

POINT

University of Kentucky

Phase 2/3 Completed

Muscular Atrophy, Neoplasms, Child Nutrition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡